Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the FINDER(R) Flu A&B/SARS-CoV-2 Test, an ultra-rapid RT-PCR assay on the FINDER platform. This establishes FINDER as the first ...
Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
MC PCR Kit is now available under the European Union's In Vitro Diagnostic Regulation (IVDR) on the myCROBE platform. The assay meets the stringent requirements of Regulation (EU) 2017/746, ...
The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research. The new system will advance personalised healthcare and support outbreak ...
Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...
Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider. U.S. Molecular Diagnostics ...
Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...
Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...
Backed by strong diagnostics market growth and industry consolidation, the transaction positions Axonia Medical to expand ...
Medical Device Network on MSN
Co-Diagnostics delivers PCR Pro instruments and TB kits to India
The development aligns with recent guidance from the WHO concerning tuberculosis molecular diagnostics in India.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results